Discharge outcome, destination, and length of stay for UIAsa
| Neurological Status at Discharge | Cerecyte (n = 133) (No.) (%) | Bare Platinum (n = 131) (No.) (%) | P |
|---|---|---|---|
| mRS 0 | 108 (81.2) | 108 (82.4) | |
| mRS 1 | 23 (17.3) | 19 (14.5) | |
| mRS 2 | 2 (1.5) | 4 (3.1) | |
| mRS ≥3 | 0 (0.0) | 0 (0.0) | |
| Death | 0 (0.0) | 0 (0.0) | |
| mRS ≥3, including death | 0 (0.0) | 0 (0.0) | – |
| Destination at discharge | |||
| Home | 131 (98.5) | 129 (98.5) | |
| Other hospital | 1 (0.8) | 2 (1.5) | |
| Rehabilitation | 1 (0.8) | 0 (0.0) | |
| Death | 0 (0.0) | 0 (0.0) | |
| Home vs rest | 131 (98.5) | 129 (98.5) | .51 |
| Length of stayb (median) (IQR) | 1 (1–2) | 2 (1–3) | .49 |